• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Hepatitis C Direct Acting Antivirals: The New Standard of Care, An Issue of Clinics in Liver Disease

Hepatitis C Direct Acting Antivirals: The New Standard of Care, An Issue of Clinics in Liver Disease

9781455711079
413.23 zł
351.25 zł Save 61.98 zł Tax included
Lowest price within 30 days before promotion: 351.25 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Hepatitis C Virus is a quickly evolving area within hepatology owing to new medical therapies. This issue, guest edited by Dr. Fred Poordad, includes the most current clinical information and treatment therapies. Expert authors have written review articles devoted to the following medical therapies:: Boceprevir, Telaprevir, Protease Inhibitors in Development, NS5B Nucleoside and Non-Nucleoside Inhibitors. Review articles also address important patients like naďve- and non-responders and relapsers, the HIV co-infected patient, and the Genotype 1 and non-Genotype 1 patient.
Product Details
Saunders
50230
9781455711079
9781455711079

Data sheet

Publication date
2011
Issue number
1
Cover
hard cover
Dimensions (mm)
152 x 229
Weight (g)
460
Comments (0)